iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
4.610
+0.160 (3.60%)
At close: Nov 20, 2024, 4:00 PM
4.450
-0.160 (-3.47%)
After-hours: Nov 20, 2024, 6:10 PM EST
iSpecimen Employees
iSpecimen had 53 employees as of December 31, 2023. The number of employees decreased by 22 or -29.33% compared to the previous year.
Employees
53
Change (1Y)
-22
Growth (1Y)
-29.33%
Revenue / Employee
$196,051
Profits / Employee
-$179,697
Market Cap
4.44M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53 | -22 | -29.33% |
Dec 31, 2022 | 75 | 16 | 27.12% |
Dec 31, 2021 | 59 | 18 | 43.90% |
Dec 31, 2020 | 41 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
Matinas BioPharma Holdings | 32 |
Theriva Biologics | 22 |
Processa Pharmaceuticals | 13 |
InMed Pharmaceuticals | 13 |
Bio-Path Holdings | 10 |
Avenue Therapeutics | 3 |
Bone Biologics | 2 |
ISPC News
- 12 days ago - iSpecimen Named Top Competitor in $4.4 Billion USD Market - Newsfile Corp
- 13 days ago - iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - GlobeNewsWire
- 20 days ago - iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 21 days ago - iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - iSpecimen Secures $1 Million Loan; Appoints Three New Board Members - GlobeNewsWire
- 2 months ago - iSpecimen Announces 1-for-20 Reverse Stock Split - GlobeNewsWire
- 3 months ago - iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - iSpecimen Reports Second Quarter 2024 Results - GlobeNewsWire